期刊文献+

炎症性肠病与免疫性肝病的研究进展 被引量:8

Research progress of inflammatory bowel disease and immuno-hepatopathy
下载PDF
导出
摘要 炎症性肠病(inflammatory bowel disease,IBD)包括溃疡性结肠炎(ulcerative colitis,UC)和克罗恩病(crohn’s disease,CD),是一种特发性肠道炎症性疾病。IBD临床表现复杂,除慢性非特异性肠道炎症外,还有皮肤、骨骼、肌、肺、肝、胆、肾脏等多个器官或系统的肠外表现。肝胆并发症因其与IBD愈后密切相关而受到关注。肝胆系统病变包括药物性肝损伤、胆结石、非酒精性脂肪肝等显性疾病,但是另外症状隐匿、特异性不强,且部分独立于肠道炎症外的免疫性肝病,如原发性硬化性胆管炎(primary sclerosing cholagitis,PSC)、小胆管性PSC、原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)、自身免疫性肝炎(AIH)、PSC/AIH重叠综合征以及Ig4相关性胆管炎容易被忽视。本文就与IBD相关的免疫性肝病的研究进展进行综述。 Inflammatory bowel disease (IBD),including ulcerative colitis (UC) and Crohn's disease(CD),is an idiopathic inflammatory bowel disease with complex clinical manifestation.Except non-specific chronic inflammatory conditions of the gastrointestinal tract,several organization or system pathological changes,like skin,bones,muscles,lungs,kidneyas well as hepatobiliary system,are extraintestinal manifestations of IBD.The complications of hepatobiliary system have drawn more attention due to its close relation with prognosis of IBD.In addition to the dominance complications of drug-induced liver damage,gallstones,nonalcoholic fatty liver disease in hepatobiliary system,other auto immuno-hepatopathies are neglected easily,which are characterized by latent,nonspecific and partly independent of intestinal inflammation,such as primary sclerosing cholangitis,a small bile ducts of PSC,primary biliary cirrhosis (PBC),autoimmune hepatitis (AIH),PSC/AIH overlap syndrome,Ig4 related cholangitis and so on.In this paper,the research progress of immuno-hepatopathies closed associated with IBD was reviewed in order to provide reliable message for early diagnosis and treatment.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第5期588-593,共6页 Chinese Journal of Gastroenterology and Hepatology
关键词 炎症性肠病 肠外表现 免疫性肝病 研究进展 Inflammatory bowel disease Extraintestinal manifestations Immuno-hepatopathy Research progress
  • 相关文献

参考文献42

  • 1Hedin CR,Mullard M,Sharratt E,et al.Probiotic and prebiotic use in patients with inflammatory bowel disease:a case-control study[J].Inflamm Bowel Dis,2010,16(12):2099-2108.
  • 2Levine JS,Burakoff R.Extraintestinal manifestations of inflammatory bowel disease[J].Gastroenterol Hepatol,2011,7 (4):235-241.
  • 3Molodeeky NA,Soon IS,Rabi DM,et al.Increasing incidence and prevalence of the inflammatory bowel diseases with time,based on systematic review[J].Gastroenterology,2012,142 (1):46-54,e42.
  • 4Prideaux L,Kamm MA,De Cruz PP,et al.Inflammatory bowel disease in Asia:a systematic review[J].J Gastroenterol Hepatol,2012,27(8):1266-1280.
  • 5Boonstra K,van Erpecum KJ,van Nieuwkerk KMJ,et al.Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease[J].Inflamm Bowel Dis,2012,18(12):2270-2276.
  • 6Wiencke K,Karlsen TH,Boberg KM,et al.Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes[J].Tissue antigens,2007,69(2):161-169.
  • 7Tabibian JH,Lindor KD.Primary sclerosing cholangitis:a review and update on therapeutic developments[J].Expert Rev Gastroenterol Hepatol,2013,7(2):103-14.
  • 8Aron JH,Bowlus CL.The immunobiology of primary sclerosing cholangitis[J].Semin Immunopathol,2009,31 (3):383-397.
  • 9Eaton JE,Talwalkar JA,Lazaridis KN,et al.Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management[J].Gastroenterology,2013,145 (3):521-536.
  • 10Moreno Luna LE,Gores GJ.Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis[J].Liver transpl,2006,12(S2):S15-S19.

二级参考文献8

共引文献9

同被引文献95

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部